适应pH的碳酸结合β-环氧德克斯纳米载体用于利沃素的输送,以提高抗生素的生物可用性
Shufen Xiao1, Yixuan Ren1, Siyu Yu1
1School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, People's Republic of China.
ACS applied bio materials
|December 31, 2025
概括
这项研究引入了对酸敏感的纳米药物载体,用于向的抗生素输送. 这些载体通过在酸性环境中释放抗生素来增强感染部位的药物生物可用性,提高疗效并减少副作用.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的抗生素具有较差的组织特异性和在感染部位的低生物可用性.
- 系统性抗生素输送可能导致健康组织中毒性和副作用.
- 酸性微环境是许多感染地点的特征.
研究的目的:
- 设计和表征一种对酸敏感的纳米药物载体,用于向的抗生素输送.
- 为了提高药物释放,利用感染地点的酸性微环境.
- 提高抗生素的生物可用性,减少与传统输送方法相关的副作用.
主要方法:
- 碳酸盐结合β-环极氨酸纳米载体 (CCCN) 通过乙烯点击反应的合成.
- 使用NMR,FTIR,XRPD,DLS和SEM进行CCCN的表征.
- 评估pH响应药物释放和抗菌活动的levofloxacin-loaded CCCN.
主要成果:
- 在酸性条件下,CCCN显示出明显的pH响应的勒沃素释放,在30小时内释放50%.
- 抗菌试验在酸性条件下显示出增强的疗效,低于最低抑制度 (12.5μg/mL在12小时).
- 与中性条件相比,纳米载体显著增加了抑制区,证实了特定部位的释放.
结论:
- 在酸性感染组织中,CCCN有效地实现了局部特定的抗生素释放.
- 这种纳米药物载体策略显著提高了抗生素的生物可用性.
- CCCN系统提供了一种有希望的方法来克服传统抗生素输送的局限性,减少副作用并改善治疗结果.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
180
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
180
Bioavailability Enhancement: Drug Permeability Enhancement
174
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
174
Bioavailability Enhancement: Drug Solubility Enhancement
197
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
197
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
5.7K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.7K
Drug Delivery: Overview
700
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
700
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
477
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
477


